Compare Novo Nordisk A/S (NVO) vs Advanced Drainage Systems Inc (WMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Advanced Drainage Systems Inc — how do they compare? Novo Nordisk A/S trades at $45.99 (market cap $207.85B), while Advanced Drainage Systems Inc trades at $139.61 (market cap $10.83B). The key difference: Novo Nordisk A/S is far larger — about 19.2× Advanced Drainage Systems Inc's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| NVO | WMS | |
|---|---|---|
Market Cap | $207.85B | $10.83B |
Sector | Health | Industrials |
52-Week High | $63.98 | $175.38 |
52-Week Low | $35.29 | $129.50 |
Enterprise Value | $222.55B | $12.44B |
Dividend Yield | 3.81% | 0.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVO trades at $47.73, up 0.99% today, with a neutral technical signal and strong fundamentals, including a P/E of 11.62 and net income margin of 35.35%. Recent Q2 2026 earnings beat expectations, but the stock faces mixed sentiment due to competitive pressures and pricing headwinds in its GLP-1 portfolio.
The outlook is cautiously optimistic, supported by robust profitability and analyst buy ratings (57.9%), but risks include intense competition from Eli Lilly and margin compression. Upside potential hinges on execution against guidance, while downside risks stem from market share erosion.
Advanced Drainage Systems (WMS) trades at $141.67, down 1.58% with bearish technical signals. The company demonstrates strong profitability with 14% net margins and consistent earnings beats, though revenue growth has moderated. Recent Q1 2027 results showed 21% sales growth to $1 billion, beating expectations. Technical indicators show resistance at $143 with support at $140, while moving averages signal bearish momentum.
WMS offers solid fundamentals with attractive upside to the $185.86 consensus target, but faces near-term technical headwinds. The company's water management solutions benefit from infrastructure spending, though competitive pressures and margin compression present risks. Analyst sentiment is mixed with 41% buy ratings, suggesting cautious optimism for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Advanced Drainage Systems Inc
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →
